Cargando…
Initiation and interruption in intravenous bisphosphonate therapy among patients with multiple myeloma in the United States
BACKGROUND: Prior to 2018, intravenous bisphosphonates (IV BPs) were the only therapies recommended to prevent skeletal‐related events for patients diagnosed with multiple myeloma (MM). We examined patterns of IV BP initiation and interruption among patients with newly diagnosed MM (NDMM) in the Uni...
Autores principales: | McGrath, Leah J., Hernandez, Rohini K., Overman, Robert, Reams, Diane, Liede, Alexander, Brookhart, M. Alan, O’Donnell, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346250/ https://www.ncbi.nlm.nih.gov/pubmed/30537194 http://dx.doi.org/10.1002/cam4.1869 |
Ejemplares similares
-
Use of bone-modifying agents among breast cancer patients with bone metastasis: evidence from oncology practices in the US
por: McGrath, Leah J, et al.
Publicado: (2018) -
Treatment Patterns Among Adults with Primary Immune Thrombocytopenia Diagnosed in Hematology Clinics in the United States
por: McGrath, Leah J, et al.
Publicado: (2020) -
Prevalence of hypercalcemia among cancer patients in the United States
por: Gastanaga, Victor M., et al.
Publicado: (2016) -
Validation of multiple myeloma risk stratification indices in routine clinical practice: Analysis of data from the Czech Myeloma Group Registry of Monoclonal Gammopathies
por: Radocha, Jakub, et al.
Publicado: (2018) -
Trends in solitary plasmacytoma, extramedullary plasmacytoma, and plasma cell myeloma incidence and myeloma mortality by racial‐ethnic group, United States 2003‐2016
por: Ellington, Taylor D., et al.
Publicado: (2020)